Review links linagliptin to lower kidney risk in diabetes

11/6/2012 | Medscape (free registration)

An analysis presented at Kidney Week 2012 showed type 2 diabetes patients who took linagliptin were 16% less likely to develop micro- and macroalbuminuria, chronic kidney disease and acute renal failure and showed lower risk of all-cause mortality compared with those in the placebo group.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA